Cashu | News | ARWR

HomeWatchlistNewsSignalsPicks

DJI

-1.23%

SPX

-1.60%

IXIC

-2.24%

FTSE

-0.70%

N225

-0.66%

AXJO

-0.92%

HomeWatchlistNewsSignalsPicks

Stocks

0.00 (0.00%)

0.000

USD

At close at --,----

Cashu is the #1 way to stay ahead of the markets, know why your favourite stocks are moving and access valuation signals that smash the market.

Company

About Us
Careers
Blog
News

Help & Support

Help Center
Contact Us
Pro Support

Legal

Privacy Policy
Terms of Use

Instagram YouTube

© 2024 Cashu PTY LTD.

Join our newsletter to keep up to date with us!

Latest Arrowhead Pharmaceuticals News

Sarepta Therapeutics Surges Over 40% In Tuesday Pre-Market: What's Going On?

Feature Image for interests on Healthcare, News, Stock, Unknown Sector from benzinga.com

Sarepta Gets Thumbs Down From Regulators Regarding Elevidys Gene Therapy

Feature Image for interests on Analyst Color, Biotech, Expert Ideas, Healthcare from benzinga.com

GE Vernova Posts Better-Than-Expected Earnings, Joins Thermo Fisher Scientific, Lennox International, General Dynamics And Other Big Stocks Moving Higher On Wednesday

Feature Image for interests on Consumer Defensive, Earnings, Financial Services, Healthcare from benzinga.com

Stocks making the biggest moves midday: Block, SolarEdge, Cleveland-Cliffs, Verizon & more

Feature Image for interests on Breaking News: Markets, Business, Communication Services, Consumer Defensive from cnbc.com

Jim Cramer: Arrowhead Pharmaceuticals Doesn't 'Have The Horses'

Feature Image for interests on Analyst Color, Cnbc, Healthcare, Industrials from benzinga.com

about 2 months ago

Cramer's Lightning Round: Dover is a buy

Feature Image for interests on Business, Consumer Discretionary, Healthcare, Industrials from cnbc.com

about 2 months ago

Tuesday’s big stock stories: What’s likely to move the market in the next trading session

Feature Image for interests on Consumer Cyclical, ETF, Energy, Financial Services from cnbc.com

businesswire.com

Arrowhead Pharmaceuticals Announces Closing of Global License and Collaboration Agreement with Sarepta Therapeutics

Feature Image for interests on Healthcare, Stock, Technology from businesswire.com

businesswire.com

Arrowhead Pharmaceuticals Announces Acceptance of New Drug Application by U.S. FDA of Plozasiran for the Treatment of Familial Chylomicronemia Syndrome

Feature Image for interests on Healthcare, Iran, Stock, Technology from businesswire.com

businesswire.com

Arrowhead Pharmaceuticals Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4)

Feature Image for interests on Healthcare, Stock, Technology from businesswire.com

Latest Cashu News

Arrowhead Pharmaceuticals: Strategic Positioning in Evolving Gene Therapy Market

Arrowhead Pharmaceuticals Faces Regulatory Setback for Elevidys DMD Treatment Approval

Arrowhead Pharmaceuticals: Innovating Therapeutics in a Rising Biotech Market

Stocks

Health Care

arwr

Arrowhead Pharmaceuticals

NASDAQ: ARWR

+0.11 (+0.73%)

15.915

USD

At close at Aug 01, 20:38 UTC